OTC · SONX
Sonendo, Inc.
$1.28$0.00 (0.0%)
Sonendo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 32.63% below the high.
Loading market information…
OTC · NVOS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Novo Integrated Sciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 87.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Novo Integrated Sciences, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:59 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.28$0.00 (0.0%)
Sonendo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 32.63% below the high.
$0.01$0.00 (0.0%)
SETO Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.07% below the high.
$0.00$0.00 (0.0%)
Black Bird Biotech, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
OMNI Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
Jack Nathan Medical Corp.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.01$0.00 (0.0%)
Panbela Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.56% below the high.
$0.00$0.00 (0.0%)
Braxia Scientific Corp.’s quoted price sits in the lower half of its reported 52-week range, 92.19% below the high.
$0.00$0.00 (0.0%)
The Amacore Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
